- Sections
- C - Chimie; métallurgie
- C12N - Micro-organismes ou enzymes; compositions les contenant; culture ou conservation de micro-organismes; techniques de mutation ou de génétique; milieux de culture
- C12N 7/06 - Inactivation ou atténuation; Production de parties élémentaires de virus par traitement chimique
Détention brevets de la classe C12N 7/06
Brevets de cette classe: 131
Historique des publications depuis 10 ans
|
4
|
8
|
10
|
10
|
9
|
11
|
7
|
13
|
3
|
1
|
| 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
Propriétaires principaux
| Proprétaire |
Total
|
Cette classe
|
|---|---|---|
| Valneva Austria GmbH | 113 |
9 |
| Valneva | 48 |
5 |
| Bharat Biotech International Limited | 96 |
4 |
| Serum Institute of India Private Limited | 100 |
4 |
| ACP Japan Co., Ltd. | 75 |
3 |
| Seqirus UK Limited | 435 |
3 |
| Takeda Vaccines, Inc. | 211 |
3 |
| Resilience Government Services, Inc. | 27 |
3 |
| Bayer HealthCare LLC | 1383 |
2 |
| National Institute of Advanced Industrial Science and Technology | 3736 |
2 |
| Novozymes A/S | 3307 |
2 |
| Takeda Pharmaceutical Company Limited | 2943 |
2 |
| Consejo Superior de Investigaciones Cientificas (csic) | 1320 |
2 |
| Elanco US Inc. | 697 |
2 |
| Shionogi & Co., Ltd. | 889 |
2 |
| The United States of America, as represented by the Secretary, Department of Health and Human Services | 2838 |
2 |
| University of Georgia Research Foundation, Inc. | 1004 |
2 |
| Adcure Biotechnologies, LLC. | 3 |
2 |
| ChemistryRX | 17 |
2 |
| Solventum Intellectual Properties Company | 3311 |
2 |
| Autres propriétaires | 73 |